These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 32892347)
1. Ppp1r3d deficiency preferentially inhibits neuronal and cardiac Lafora body formation in a mouse model of the fatal epilepsy Lafora disease. Israelian L; Nitschke S; Wang P; Zhao X; Perri AM; Lee JPY; Verhalen B; Nitschke F; Minassian BA J Neurochem; 2021 Jun; 157(6):1897-1910. PubMed ID: 32892347 [TBL] [Abstract][Full Text] [Related]
2. Astrocytic glycogen accumulation drives the pathophysiology of neurodegeneration in Lafora disease. Duran J; Hervera A; Markussen KH; Varea O; López-Soldado I; Sun RC; Del Río JA; Gentry MS; Guinovart JJ Brain; 2021 Sep; 144(8):2349-2360. PubMed ID: 33822008 [TBL] [Abstract][Full Text] [Related]
3. An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice. Nitschke S; Chown EE; Zhao X; Gabrielian S; Petković S; Guisso DR; Perri AM; Wang P; Ahonen S; Nitschke F; Minassian BA J Biol Chem; 2021; 296():100150. PubMed ID: 33277363 [TBL] [Abstract][Full Text] [Related]
4. Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons. Wang Y; Ma K; Wang P; Baba O; Zhang H; Parent JM; Zheng P; Liu Y; Minassian BA; Liu Y Mol Neurobiol; 2013 Aug; 48(1):49-61. PubMed ID: 23546741 [TBL] [Abstract][Full Text] [Related]
5. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin. DePaoli-Roach AA; Tagliabracci VS; Segvich DM; Meyer CM; Irimia JM; Roach PJ J Biol Chem; 2010 Aug; 285(33):25372-81. PubMed ID: 20538597 [TBL] [Abstract][Full Text] [Related]
6. Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice. Machado-Salas J; Avila-Costa MR; Guevara P; Guevara J; Durón RM; Bai D; Tanaka M; Yamakawa K; Delgado-Escueta AV Exp Neurol; 2012 Jul; 236(1):131-40. PubMed ID: 22542948 [TBL] [Abstract][Full Text] [Related]
7. Astrocytes: new players in progressive myoclonus epilepsy of Lafora type. Rubio-Villena C; Viana R; Bonet J; Garcia-Gimeno MA; Casado M; Heredia M; Sanz P Hum Mol Genet; 2018 Apr; 27(7):1290-1300. PubMed ID: 29408991 [TBL] [Abstract][Full Text] [Related]
8. Glycogen hyperphosphorylation underlies lafora body formation. Turnbull J; Wang P; Girard JM; Ruggieri A; Wang TJ; Draginov AG; Kameka AP; Pencea N; Zhao X; Ackerley CA; Minassian BA Ann Neurol; 2010 Dec; 68(6):925-33. PubMed ID: 21077101 [TBL] [Abstract][Full Text] [Related]
9. A PTG variant contributes to a milder phenotype in Lafora disease. Guerrero R; Vernia S; Sanz R; Abreu-Rodríguez I; Almaraz C; García-Hoyos M; Michelucci R; Tassinari CA; Riguzzi P; Nobile C; Sanz P; Serratosa JM; Gómez-Garre P PLoS One; 2011; 6(6):e21294. PubMed ID: 21738631 [TBL] [Abstract][Full Text] [Related]
10. Glycogenic activity of R6, a protein phosphatase 1 regulatory subunit, is modulated by the laforin-malin complex. Rubio-Villena C; Garcia-Gimeno MA; Sanz P Int J Biochem Cell Biol; 2013 Jul; 45(7):1479-88. PubMed ID: 23624058 [TBL] [Abstract][Full Text] [Related]
11. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease. Nitschke F; Sullivan MA; Wang P; Zhao X; Chown EE; Perri AM; Israelian L; Juana-López L; Bovolenta P; Rodríguez de Córdoba S; Steup M; Minassian BA EMBO Mol Med; 2017 Jul; 9(7):906-917. PubMed ID: 28536304 [TBL] [Abstract][Full Text] [Related]
12. Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease. Valles-Ortega J; Duran J; Garcia-Rocha M; Bosch C; Saez I; Pujadas L; Serafin A; Cañas X; Soriano E; Delgado-García JM; Gruart A; Guinovart JJ EMBO Mol Med; 2011 Nov; 3(11):667-81. PubMed ID: 21882344 [TBL] [Abstract][Full Text] [Related]
13. Lack of p62 Impairs Glycogen Aggregation and Exacerbates Pathology in a Mouse Model of Myoclonic Epilepsy of Lafora. Pellegrini P; Hervera A; Varea O; Brewer MK; López-Soldado I; Guitart A; Aguilera M; Prats N; Del Río JA; Guinovart JJ; Duran J Mol Neurobiol; 2022 Feb; 59(2):1214-1229. PubMed ID: 34962634 [TBL] [Abstract][Full Text] [Related]